Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years

Clinical Endocrinology

Volumn 67, Issue 2, 2007, Pages 270-275

  Bolland, Mark J ^a   Grey, Andrew B ^a   Horne, Anne M ^a   Briggs, Simon E ^a,b   Thomas, Mark G ^a,b   Ellis Pegler, Rod B ^a,b   Woodhouse, Andrew F ^b   Gamble, Greg D ^a   Reid, Ian R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ANTIRETROVIRUS AGENT; CALCIUM; PARATHYROID HORMONE; TESTOSTERONE;

ADULT; AGE DISTRIBUTION; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY FAT; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMUR; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEAN BODY WEIGHT; LUMBAR SPINE; MALE; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY COMPOSITION; BONE DENSITY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 34447507955     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02875.x     Document Type: Article

References (59)

1. Tebas, P., Powderly, W.G., Claxton, S., Marin, D., Tantisiriwat, W., Teitelbaum, S.L. Yarasheski, K.E. (2000) Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS, 14, F63 F67.
2. Carr, A., Miller, J., Eisman, J.A. Cooper, D.A. (2001) Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS, 15, 703 709.
3. Fairfield, W.P., Finkelstein, J.S., Klibanski, A. Grinspoon, S.K. (2001) Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome. Journal of Clinical Endocrinology and Metabolism, 86, 2020 2026.
4. Huang, J.S., Rietschel, P., Hadigan, C.M., Rosenthal, D.I. Grinspoon, S. (2001) Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy. AIDS, 15, 975 982.
5. Huang, J.S., Wilkie, S.J., Sullivan, M.P. Grinspoon, S. (2001) Reduced bone density in androgen-deficient women with acquired immune deficiency syndrome wasting. Journal of Clinical Endocrinology and Metabolism, 86, 3533 3539.
6. Knobel, H., Guelar, A., Vallecillo, G., Nogues, X. Diez, A. (2001) Osteopenia in HIV-infected patients: is it the disease or is it the treatment? AIDS, 15, 807 808.
7. Lawal, A., Engelson, E.S., Wang, J., Heymsfield, S.B. Kotler, D.P. (2001) Equivalent osteopenia in HIV-infected individuals studied before and during the era of highly active antiretroviral therapy. AIDS, 15, 278 280.
8. Moore, A.L., Vashisht, A., Sabin, C.A., Mocroft, A., Madge, S., Phillips, A.N., Studd, J.W. Johnson, M.A. (2001) Reduced bone mineral density in HIV-positive individuals. AIDS, 15, 1731 1733.
9. Nolan, D., Upton, R., McKinnon, E., John, M., James, I., Adler, B., Roff, G., Vasikaran, S. Mallal, S. (2001) Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir. AIDS, 15, 1275 1280.
10. Gold, J., Pocock, N. Li, Y. (2002) Bone mineral density abnormalities in patients with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 30, 131 132.
11. Loiseau-Peres, S., Delaunay, C., Poupon, S., Lespessailles, E., Ballouche, N., Arsac, P. Benhamou, C.L. (2002) Osteopenia in patients infected by the human immunodeficiency virus. A case control study. Joint Bone Spine, 69, 482 485.
12. Bruera, D., Luna, N., David, D.O., Bergoglio, L.M. Zamudio, J. (2003) Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS, 17, 1917 1923.
13. Fernandez-Rivera, J., Garcia, R., Lozano, F., Macias, J., Garcia-Garcia, J.A., Mira, J.A., Corzo, J.E., Gomez-Mateos, J., Rueda, A., Sanchez-Burson, J. Pineda, J.A. (2003) Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients. HIV Clinical Trials, 4, 337 346.
14. Mondy, K., Yarasheski, K., Powderly, W.G., Whyte, M., Claxton, S., DeMarco, D., Hoffmann, M. Tebas, P. (2003) Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clinical Infectious Diseases, 36, 482 490.
15. Vescini, F., Borderi, M., Buffa, A., Sinicropi, G., Tampellini, L., Chiodo, F. Caudarella, R. (2003) Bone mass in HIV-infected patients: focus on the role of therapy and sex. Journal of Acquired Immune Deficiency Syndromes, 33, 405 407.
16. Amiel, C., Ostertag, A., Slama, L., Baudoin, C., N'Guyen, T., Lajeunie, E., Neit-Ngeilh, L., Rozenbaum, W. De Vernejoul, M.C. (2004) BMD is reduced in HIV-infected men irrespective of treatment. Journal of Bone and Mineral Research, 19, 402 409.
17. Brown, T.T., Ruppe, M.D., Kassner, R., Kumar, P., Kehoe, T., Dobs, A.S. Timpone, J. (2004) Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia. Journal of Clinical Endocrinology and Metabolism, 89, 1200 1206.
18. Dolan, S.E., Huang, J.S., Killilea, K.M., Sullivan, M.P., Aliabadi, N. Grinspoon, S. (2004) Reduced bone density in HIV-infected women. AIDS, 18, 475 483.
19. Landonio, S., Quirino, T., Bonfanti, P., Gabris, A., Boccassini, L., Gulisano, C., Vulpio, L., Ricci, E., Carrabba, M. Vigevani, G.M. (2004) Osteopenia and osteoporosis in HIV+ patients, untreated or receiving HAART. Biomedicine and Pharmacotherapy, 58, 505 508.
20. Madeddu, G., Spanu, A., Solinas, P., Calia, G.M., Lovigu, C., Chessa, F., Mannazzu, M., Falchi, A. Mura, M.S. (2004) Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Quarterly Journal of Nuclear Medicine and Molecular Imaging, 48, 39 48.
21. Bongiovanni, M., Fausto, A., Cicconi, P., Menicagli, L., Melzi, S., Ligabo, V.E., Cornalba, G., Bini, T., Sardanelli, F. Monforte, A.D. (2005) Osteoporosis in HIV-infected subjects: a combined effect of highly active antiretroviral therapy and HIV itself? Journal of Acquired Immune Deficiency Syndromes, 40, 503 504.
22. Bonnet, E., Delpierre, C., Sommet, A., Marion-Latard, F., Herve, R., Aquilina, C., Labau, E., Obadia, M., Marchou, B., Massip, P., Perret, B. Bernard, J. (2005) Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy. Journal of Clinical Densitometry, 8, 287 292.
23. Konishi, M., Takahashi, K., Yoshimoto, E., Uno, K., Kasahara, K. Mikasa, K. (2005) Association between osteopenia/osteoporosis and the serum RANKL in HIV-infected patients. AIDS, 19, 1240 1241.
24. Koutkia, P., Canavan, B., Breu, J. Grinspoon, S. (2005) Effects of growth hormone-releasing hormone on bone turnover in human immunodeficiency virus-infected men with fat accumulation. Journal of Clinical Endocrinology and Metabolism, 90, 2154 2160.
25. Ozcakar, L., Guven, G.S., Unal, S. Akinci, A. (2005) Osteoporosis In Turkish HIV/AIDS patients: comparative analysis by dual energy X-ray absorptiometry and digital X-ray radiogrammetry. Osteoporosis International, 16, 1363 1367.
26. Seminari, E., Castagna, A., Soldarini, A., Galli, L., Fusetti, G., Dorigatti, F., Hasson, H., Danise, A., Guffanti, M., Lazzarin, A. Rubinacci, A. (2005) Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients. HIV Medicine, 6, 145 150.
27. Yin, M., Dobkin, J., Brudney, K., Becker, C., Zadel, J.L., Manandhar, M., Addesso, V. Shane, E. (2005) Bone mass and mineral metabolism in HIV+ postmenopausal women. Osteoporosis International, 16, 1345 1352.
28. Arnsten, J.H., Freeman, R., Howard, A.A., Floris-Moore, M., Santoro, N. Schoenbaum, E.E. (2006) HIV infection and bone mineral density in middle-aged women. Clinical Infectious Diseases, 42, 1014 1020.
29. Bongiovanni, M., Fausto, A., Cicconi, P., Aliprandi, A., Cornalba, G., Bini, T., Sardanelli, F. Monforte, A.D. (2006) Non-nucleoside-reverse- transcriptase-inhibitor-based HAART and osteoporosis in HIV-infected subjects. Journal of Antimicrobial Chemotherapy, 58, 485 486.
30. Curtis, J.R., Smith, B., Weaver, M., Landers, K., Lopez-Ben, R., Raper, J.L., Saag, M., Venkataraman, R. Saag, K.G. (2006) Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodystrophy. AIDS Research and Human Retroviruses, 22, 125 131.
31. Dolan, S.E., Kanter, J.R. Grinspoon, S. (2006) Longitudinal analysis of bone density in human immunodeficiency virus-infected women. Journal of Clinical Endocrinology and Metabolism, 91, 2938 2945.
32. Fausto, A., Bongiovanni, M., Cicconi, P., Menicagli, L., Ligabo, E.V., Melzi, S., Bini, T., Sardanelli, F., Cornalba, G. Monforte, A. (2006) Potential predictive factors of osteoporosis in HIV-positive subjects. Bone, 38, 893 897.
33. Garcia Aparicio, A.M., Munoz Fernandez, S., Gonzalez, J., Arribas, J.R., Pena, J.M., Vazquez, J.J., Martinez, M.E., Coya, J. Martin Mola, E. (2006) Abnormalities in the bone mineral metabolism in HIV-infected patients. Clinical Rheumatology, 25, 537 539.
34. Bolland, M.J., Grey, A.B., Horne, A.M., Briggs, S.E., Thomas, M.G., Ellis-Pegler, R.B., Woodhouse, A.F., Gamble, G.D. Reid, I.R. (2006) Bone mineral density is not reduced in HIV-infected Caucasian men treated with highly active antiretroviral therapy. Clinical Endocrinology, 65, 191 197.
35. Cirelli, A., Cirelli, G., Balsamo, G., Masciangelo, R., Stasolla, A. Marini, M. (2003) Body habitus changes, metabolic abnormalities, osteopenia and cardiovascular risk in patients treated for human immunodeficiency virus infection. Annali Italiani di Medicina Interna, 18, 238 245.
36. Gallant, J.E., Staszewski, S., Pozniak, A.L., DeJesus, E., Suleiman, J.M., Miller, M.D., Coakley, D.F., Lu, B., Toole, J.J. Cheng, A.K. (2004) Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. Journal of the American Medical Association, 292, 191 201.
37. Martin, A., Smith, D.E., Carr, A., Ringland, C., Amin, J., Emery, S., Hoy, J., Workman, C., Doong, N., Freund, J. Cooper, D.A. (2004) Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study. AIDS, 18, 1029 1036.
38. McComsey, G.A., Ward, D.J., Hessenthaler, S.M., Sension, M.G., Shalit, P., Lonergan, J.T., Fisher, R.L., Williams, V.C. Hernandez, J.E. (2004) Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study. Clinical Infectious Diseases, 38, 263 270.
39. Tebas, P., Yarasheski, K., Henry, K., Claxton, S., Kane, E., Bordenave, B., Klebert, M. Powderly, W.G. (2004) Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection. AIDS Research and Human Retroviruses, 20, 589 594.
40. Amorosa, V. Tebas, P. (2006) Bone disease and HIV infection. Clinical Infectious Diseases, 42, 108 114.
41. Thomas, J. Doherty, S.M. (2003) HIV infection - a risk factor for osteoporosis. Journal of Acquired Immune Deficiency Syndromes, 33, 281 291.
42. Reid, I.R. (2002) Relationships among body mass, its components, and bone. Bone, 31, 547 555.
43. Ward, K.D. Klesges, R.C. (2001) A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcified Tissue International, 68, 259 270.
44. Hannan, M.T., Felson, D.T., Dawson-Hughes, B., Tucker, K.L., Cupples, L.A., Wilson, P.W. Kiel, D.P. (2000) Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. Journal of Bone and Mineral Research, 15, 710 720.
45. Wu, F., Ames, R., Clearwater, J., Evans, M.C., Gamble, G. Reid, I.R. (2002) Prospective 10-year study of the determinants of bone density and bone loss in normal postmenopausal women, including the effect of hormone replacement therapy. Clinical Endocrinology, 56, 703 711.
46. Wang, M.W.-H., Wei, S., Faccio, R., Takeshita, S., Tebas, P., Powderly, W.G., Teitelbaum, S.L. Ross, F.P. (2004) The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling. Journal of Clinical Investigation, 114, 206 213.
47. Wang, M., Wei, S., Teitelbaum, S. Ross, F. (2001) The HIV protease inhibitor indinavir uniquely inhibits bone formation. Journal of Bone and Mineral Research, 16, S372.
48. Jain, R.G. Lenhard, J.M. (2002) Select HIV protease inhibitors alter bone and fat metabolism ex vivo. Journal of Biological Chemistry, 277, 19247 19250.
49. Monier, P.L. Wilcox, R. (2004) Metabolic complications associated with the use of highly active antiretroviral therapy in HIV-1-infected adults. American Journal of Medical Science, 328, 48 56.
50. Guaraldi, G., Orlando, G., Madeddu, G., Vescini, F., Ventura, P., Campostrini, S., Mura, M.S., Parise, N., Caudarella, R. Esposito, R. (2004) Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis. HIV Clinical Trials, 5, 269 277.
51. Mondy, K., Powderly, W.G., Claxton, S.A., Yarasheski, K.H., Royal, M., Stoneman, J.S., Hoffmann, M.E. Tebas, P. (2005) Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 38, 426 431.
52. Negredo, E., Martinez-Lopez, E., Paredes, R., Rosales, J., Perez-Alvarez, N., Holgado, S., Gel, S., del Rio, L., Tena, X., Rey-Joly, C. Clotet, B. (2005) Reversal of HIV-1-associated osteoporosis with once-weekly alendronate. AIDS, 19, 343 345.
53. Stephens, E.A., Das, R., Madge, S., Barter, J. Johnson, M.A. (1999) Symptomatic osteoporosis in two young HIV-positive African women. AIDS, 13, 2605 2606.
54. Guaraldi, G., Ventura, P., Albuzza, M., Orlando, G., Bedini, A., Amorico, G. Esposito, R. (2001) Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy. AIDS, 15, 137 138.
55. Forsyth, S.F., Gazzard, B.G. Nelson, M.R. (2002) A case of march fracture in a patient with osteoporosis on long-term HAART. International Journal of STD and AIDS, 13, 645 646.
56. McComsey, G.A., Huang, J.S., Woolley, I.J., Young, B., Sax, P.E., Gerber, M., Swindells, S., Bonilla, H. Gopalakrishnan, G. (2004) Fragility fractures in HIV-infected patients: need for better understanding of diagnosis and management. Journal of the International Association of Physicians in AIDS Care, 3, 86 91.
57. National Osteoporosis Foundation (2003) Physician's Guide to Prevention and Treatment of Osteoporosis. National Osteoporosis Foundation, Washington, DC.
58. American Association of Clinical Endocrinologists (2003) Medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis. Endocrine Practice, 9, 545 564.
59. Bolland, M.J., Grey, A.B., Horne, A.M., Briggs, S.E., Thomas, M.G., Ellis-Pegler, R.B., Woodhouse, A.F., Gamble, G.D. Reid, I.R. (2007) Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial. Journal of Clinical Endocrinology and Metabolism, 92, 1283 1288.